These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 26921291)
1. Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens. Vassilakopoulos TP; Dimopoulou MN; Angelopoulou MK; Petevi K; Pangalis GA; Moschogiannis M; Dimou M; Boutsikas G; Kanellopoulos A; Gainaru G; Plata E; Flevari P; Koutsi K; Papageorgiou L; Telonis V; Tsaftaridis P; Sachanas S; Yiakoumis X; Tsirkinidis P; Viniou NA; Siakantaris MP; Variami E; Kyrtsonis MC; Meletis J; Panayiotidis P; Konstantopoulos K Oncologist; 2016 Mar; 21(3):343-53. PubMed ID: 26921291 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages. Jakovic LR; Mihaljevic BS; Andjelic BM; Bogdanovic AD; Perunicic Jovanovic MD; Babic DD; Bumbasirevic VZ Leuk Lymphoma; 2016 Aug; 57(8):1839-47. PubMed ID: 26727349 [TBL] [Abstract][Full Text] [Related]
3. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685 [TBL] [Abstract][Full Text] [Related]
4. Comparison of prognostic impact of absolute lymphocyte count, absolute monocyte count, absolute lymphocyte count/absolute monocyte count prognostic score and ratio in patients with diffuse large B cell lymphoma. Markovic O; Popovic L; Marisavljevic D; Jovanovic D; Filipovic B; Stanisavljevic D; Matovina-Brko G; Hajder J; Matkovic T; Živkovic R; Stanisavljevic N; Todorović M; Petrovic D; Mihaljevic B Eur J Intern Med; 2014 Mar; 25(3):296-302. PubMed ID: 24565533 [TBL] [Abstract][Full Text] [Related]
5. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages. Koh YW; Kang HJ; Park C; Yoon DH; Kim S; Suh C; Go H; Kim JE; Kim CW; Huh J Oncologist; 2012; 17(6):871-80. PubMed ID: 22588324 [TBL] [Abstract][Full Text] [Related]
6. Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy. Romano A; Parrinello NL; Vetro C; Chiarenza A; Cerchione C; Ippolito M; Palumbo GA; Di Raimondo F Ann Hematol; 2018 Jun; 97(6):1009-1018. PubMed ID: 29442162 [TBL] [Abstract][Full Text] [Related]
7. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma]. Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study. Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM; Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326 [TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era. Aoki K; Tabata S; Yonetani N; Matsushita A; Ishikawa T Acta Haematol; 2013; 130(4):242-6. PubMed ID: 23860478 [TBL] [Abstract][Full Text] [Related]
10. The lower peripheral blood lymphocyte/monocyte ratio assessed during routine follow-up after standard first-line chemotherapy is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma. Yan-Li L; Kang-Sheng G; Yue-Yin P; Yang J; Zhi-Min Z Leuk Res; 2014 Mar; 38(3):323-8. PubMed ID: 24439567 [TBL] [Abstract][Full Text] [Related]
12. Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era. Ho CL; Lu CS; Chen JH; Chen YG; Huang TC; Wu YY Medicine (Baltimore); 2015 Jun; 94(24):e993. PubMed ID: 26091479 [TBL] [Abstract][Full Text] [Related]
13. Peripheral blood lymphocyte/monocyte ratio predicts outcome for patients with diffuse large B cell lymphoma after standard first-line regimens. Li YL; Pan YY; Jiao Y; Ning J; Fan YG; Zhai ZM Ann Hematol; 2014 Apr; 93(4):617-26. PubMed ID: 24141331 [TBL] [Abstract][Full Text] [Related]
14. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A; J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Absolute Lymphocyte Count, Absolute Monocyte Count, and Absolute Lymphocyte Count to Absolute Monocyte Count Ratio in Follicular Non-Hodgkin Lymphoma. Mohsen A; Taalab M; Abousamra N; Mabed M Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e606-e615. PubMed ID: 32303487 [TBL] [Abstract][Full Text] [Related]
16. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned. Viviani S; Zinzani PL; Rambaldi A; Brusamolino E; Levis A; Bonfante V; Vitolo U; Pulsoni A; Liberati AM; Specchia G; Valagussa P; Rossi A; Zaja F; Pogliani EM; Pregno P; Gotti M; Gallamini A; Rota Scalabrini D; Bonadonna G; Gianni AM; ; ; N Engl J Med; 2011 Jul; 365(3):203-12. PubMed ID: 21774708 [TBL] [Abstract][Full Text] [Related]
17. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial. Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976 [TBL] [Abstract][Full Text] [Related]
18. Treatment results in advanced stage Hodgkin's lymphoma: a retrospective study. Jain H; Sengar M; Nair R; Menon H; Laskar S; Shet T; Gujral S; Sridhar E J Postgrad Med; 2015; 61(2):88-91. PubMed ID: 25766339 [TBL] [Abstract][Full Text] [Related]
19. Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma. Kumagai S; Tashima M; Fujikawa J; Iwasaki M; Iwamoto Y; Sueki Y; Fukunaga A; Yanagita S; Nishikori M; Takaori-Kondo A; Arima N Int J Hematol; 2014 Jun; 99(6):737-42. PubMed ID: 24756873 [TBL] [Abstract][Full Text] [Related]
20. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease. Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]